In scientific research and laboratories, I’m exploring
Science & drug discovery AI
The answer · All companies tracked on usedby
Companies use Cradle most, then Causaly.
14 of 34 companies tracked in this category use Cradle. Every line links to a public source.
counts are companies tracked on usedby, not market shareLimited beta
Science & drug discovery AI
Tool by tool
34 companies tracked in this category · 4 tools
About these numbers
Counts cover companies recorded on usedby. They are not market shares. All four proof levels count. Missing size data is excluded only from size-based views. Your requirements have not been evaluated.
Companies with known size: 97%. Vendor companies excluded from this category: 0.

Cradle
14 companies41% of the companies in this sample
14 observed

Causaly
13 companies38% of the companies in this sample
3 confirmed10 observed
Manas AI uses Causaly as its primary platform for target identification and validation in drug discovery, running evidence assessments across human genetics, preclinical, clinical, competitor and safety data before committing resources to a target.
Manas AIRead the sourceOriginal source text
Manas AI uses Causaly as its primary platform for target identification and validation.

Chai Discovery
7 companies21% of the companies in this sample
7 confirmed

Owkin
5 companies15% of the companies in this sample
4 confirmed1 observed
Cleveland Clinic Abu Dhabi worked with Owkin on a proof of concept in prostate cancer, using K Pro to turn siloed, unstructured clinical data into a queryable patient registry.
Cleveland Clinic Abu DhabiRead the sourceOriginal source text
We showed concrete value: identifying patients and exploring their characteristics in seconds, while drastically reducing the time-to-insight with potential applications for tumor board meetings.
Category, industry and company size
Company size describes the employer. It does not establish access for a solo practitioner.












